Since TET1 had been previously shown to be inhibited in both in vivo and in vitro NAFLD models, we then explored the role of complete deficiency of TET1 (TET1 knockout) in hepatic steatosis. Here, TET1 is linked to metabolic dysfunction-associated steatotic liver disease.